Info
Dr. Lecia Sequist provides her thoughts on how molecular oncology can soon begin affecting treatment plans for a broader range of patients with lung cancer, including those with squamous NSCLC and other lung cancer histologies.
8 anni fa
#adenocarcinoma, #advanced, #cancergrace, #general, #grace, #gracecast, #histology, #hospital, #lecia, #marker, #markers, #massachusetts, #molecular, #mutation, #nsclc, #oncology, #squamous, #targeted, #testing, #therapies
Scopri di più
Cerca
